NewcelX Shares Outstanding History (NCEL)
NewcelX reported 4.8M shares outstanding at the end of fiscal 2025.
View full NewcelX company overviewNewcelX annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 4.8M | 1.8M | +62.04% |
| 2024 | 2024-12-31 | 3.0M | 2.2M | +265.20% |
| 2023 | 2023-12-31 | 810,722 | −31.6M | −97.50% |
| 2022 | 2022-12-31 | 32.4M | 16.2M | +99.89% |
| 2021 | 2021-12-31 | 16.2M | 9.3M | +133.09% |
| 2020 | 2020-12-31 | 7.0M | 0 | 0.00% |
| 2019 | 2019-12-31 | 7.0M | — | — |
NewcelX quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 4.8M | 4.0M | +491.76% |
| Q2 2025 | 2025-06-30 | 4.2M | −31.5M | −88.36% |
| Q4 2024 | 2024-12-31 | 3.0M | −29.5M | −90.87% |
| Q2 2024 | 2024-06-30 | 985,723 | −16.8M | −94.46% |
| Q4 2023 | 2023-12-31 | 810,722 | −15.4M | −95.00% |
| Q2 2023 | 2023-06-30 | 35.7M | 23.6M | +195.58% |
| Q4 2022 | 2022-12-31 | 32.4M | 25.5M | +365.93% |
| Q2 2022 | 2022-06-30 | 17.8M | 10.8M | +155.54% |
| Q4 2021 | 2021-12-31 | 16.2M | — | — |
| Q2 2021 | 2021-06-30 | 12.1M | — | — |
| Q4 2020 | 2020-12-31 | 7.0M | — | — |
| Q4 2019 | 2019-12-31 | 7.0M | — | — |
NewcelX shares outstanding trends
Over the last five reported fiscal years, NewcelX's shares outstanding moved from 7.0M to 4.8M, a change of −2.2M. The latest reported quarter, Q4 2025, shows 4.8M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NewcelX filings at SEC.gov ↗